Nerelimomab Antibody
Nerelimomab (BAYX1351) is a monoclonal antibody targeting TNF-α, employed in sepsis research. It has been investigated in clinical and preclinical studies to modulate the inflammatory cytokine response associated with severe sepsis and septic shock.
Product Specifications
Target
TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog